Digoxin - time to take the gloves off? - PubMed (original) (raw)
Review
. 2013 Apr 15;164(3):365-7.
doi: 10.1016/j.ijcard.2011.07.034. Epub 2011 Jul 31.
Affiliations
- PMID: 21807421
- DOI: 10.1016/j.ijcard.2011.07.034
Review
Digoxin - time to take the gloves off?
Emma Eade et al. Int J Cardiol. 2013.
Abstract
Digoxin has been used for hundreds of years to aid rate control in atrial fibrillation and as a positive inotrope in heart failure. Our familiarity with digoxin has allowed it to become easily prescribed even though there are data suggesting that use of digoxin may in fact result in increased mortality and pro-arrhythmia. Within this review we explain some of the outcome data associated with digoxin use to determine if it is time to take the gloves off and examine if we should still be using this drug in the 21st century.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
- Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
Al-Zakwani I, Panduranga P, Zubaid M, Sulaiman K, Rashed WA, Alsheikh-Ali AA, AlMahmeed W, Shehab A, Al Qudaimi A, Asaad N, Amin H. Al-Zakwani I, et al. J Cardiovasc Pharmacol Ther. 2016 May;21(3):273-9. doi: 10.1177/1074248415603505. Epub 2015 Sep 3. J Cardiovasc Pharmacol Ther. 2016. PMID: 26341119 - Use of digoxin for heart failure and atrial fibrillation in elderly patients.
Cheng JW, Rybak I. Cheng JW, et al. Am J Geriatr Pharmacother. 2010 Oct;8(5):419-27. doi: 10.1016/j.amjopharm.2010.10.001. Am J Geriatr Pharmacother. 2010. PMID: 21335295 Review. - [Posologic factors of digoxin in Catalonia].
Navarro Moreno LA, Maldonado Pardo R, García González I, Reig Puig L. Navarro Moreno LA, et al. An Med Interna. 1999 Oct;16(10):543-4. An Med Interna. 1999. PMID: 10603679 Spanish. No abstract available. - Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
Shah M, Avgil Tsadok M, Jackevicius CA, Essebag V, Behlouli H, Pilote L. Shah M, et al. Am J Cardiol. 2014 Aug 1;114(3):401-6. doi: 10.1016/j.amjcard.2014.05.013. Epub 2014 May 16. Am J Cardiol. 2014. PMID: 24950677 Clinical Trial. - Is there a role for digoxin in atrial fibrillation without heart failure?
Master J, Schweitzer P. Master J, et al. Cardiol J. 2009;16(5):483-6. Cardiol J. 2009. PMID: 19753533 Review.
Cited by
- Hypoxia-inducible factor 1 and cardiovascular disease.
Semenza GL. Semenza GL. Annu Rev Physiol. 2014;76:39-56. doi: 10.1146/annurev-physiol-021113-170322. Epub 2013 Aug 21. Annu Rev Physiol. 2014. PMID: 23988176 Free PMC article. Review. - Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-β signaling.
Wei H, Bedja D, Koitabashi N, Xing D, Chen J, Fox-Talbot K, Rouf R, Chen S, Steenbergen C, Harmon JW, Dietz HC, Gabrielson KL, Kass DA, Semenza GL. Wei H, et al. Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):E841-50. doi: 10.1073/pnas.1202081109. Epub 2012 Mar 8. Proc Natl Acad Sci U S A. 2012. PMID: 22403061 Free PMC article. Retracted. - REV-ERB and ROR nuclear receptors as drug targets.
Kojetin DJ, Burris TP. Kojetin DJ, et al. Nat Rev Drug Discov. 2014 Mar;13(3):197-216. doi: 10.1038/nrd4100. Nat Rev Drug Discov. 2014. PMID: 24577401 Free PMC article. Review. - The effect of calcium in water hardness on digoxin plasma levels in an experimental rat model.
Shahsavand S, Moshirfar M, Seyed-Sharifi SH, Younessi-Heravi MA, Ghasemi R, Valaei M, Yaghubi M. Shahsavand S, et al. ARYA Atheroscler. 2020 Sep;16(5):235-243. doi: 10.22122/arya.v16i5.2112. ARYA Atheroscler. 2020. PMID: 33889190 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical